Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,813.42
(
-0.16%
)
US TECH 100
24,406.80
(
0.00%
)
Dow Jones
47,889.74
(
-0.61%
)
Brent Oil
94.60
(
0.15%
)
Bitcoin
72,971.01
(
1.65%
)
News Focus
News Focus
Post# of 2379774
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

$ubmachine

Send PM Follow Ignore
Followers 45
Posts 4646
Boards Moderated 0
Alias Born 11/19/2006

$ubmachine

Re: fink post# 2315012

Friday, 04/14/2023 4:04:21 AM

Friday, April 14, 2023 4:04:21 AM

Post# of 2379774
Alpha Synuclein is key protein which plays main role in yesterday`s Parkinson Breakthrough News from MJFF

ACIU again had from all related companies the most number of Alpha Synuclein drugs under development in 2022 !!!

From their current pipeline:
In their Parkinson related Clinical stage program ACI-7104 and ACI-12589 are on alpha-synuclein for Parkinsons desease.
In their Parkinson related Novel targets program Anti-a-syn antibody and Morphomer® a-syn aggregation inhibitor are on alpha-synuclein for Parkinsons desease.

See complete ACIU pipeline
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today